1 Introduction 1.1 Peptide drug products and T cell dependent immunogenicity Ensuring drug safety and efficacy is of utmost importance for bringing novel and generic peptide drug products to market
The most common experience during week 1 includes: Mild-to-moderate nausea, especially after eating Reduced appetite and an earlier feeling of fullness Possible fatigue or low energy as calorie intake drops Mild headache, often linked to reduced food and fluid intake The starting dose for Ozempic is 0.25 mg weekly
If you want to optimise your microneedling protocol: The data suggests that longer treatment duration (36 months minimum) and less aggressive session frequency (fortnightly rather than weekly) may actually produce better results than trying to do more, more often
Prescription medications are not sold by the clinic and are not offered as standalone treatments
When reviewing tirzepatide to other products for diabetes, its efficacy is promising as seen in the following table
We work together with your diabetes care team to determine whether continuing, modifying, or changing your medication is the safest choice based on your specific situation
